Alzheimer’s Disease Connectome Project (ADCP)
The ADCP aimed to develop robust technology to accurately stage Alzheimer’s disease across the full spectrum of its progression on an individual subject basis. The cohort consisted of approximately 200 individuals aged 55 years or older, including individuals who were cognitively healthy, had mild cognitive impairment (MCI) or had Alzheimer's disease (AD), recruited in the United States of America. Baseline assessments began in 2020, and participants were followed up in 2021-2022.
Study design
Cohort, Cohort - research programme, Cohort - clinical
Number of participants at first data collection
198 (participants)
Age at first data collection
≥ 55 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
White, Black or African American, and Hispanic/Non-Hispanic individuals in the United States of America.
Sample features
Country
Year of first data collection
2020
Primary Institutions
Medical College of Wisconsin (MCW)
University of Wisconsin-Madison
Profile paper DOI
Not available
Funders
National Institutes of Health (NIH)
Ongoing?
No
Data types collected
- Activity log (e.g. food, sleep, exercise)
- Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
- Interview – face-to-face
- Interview – online
- Interview – phone
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Self-completed questionnaire – paper or computer assisted
- Self-completed questionnaire – online
- None
- Diffusion Tensor Imaging (DTI)
- Functional magnetic resonance imaging (fMRI)
- Magnetic Resonance Imaging (MRI)
- None
Engagement
Keywords
Consortia and dataset groups
